Quetiapine Extended Release Depression Symptoms - ExAttitude

Exclusion Criteria

• - Any DSM-IV Axis I disorder other than schizophrenia and schizoaffective disorder
• - Patients treated with depot antipsychotic medications within 1 dosing interval before day 0; patients treated with other AP oral medications during the trial except for the switch period
• - Use of Clozapine within 28 days prior to enrollment or Clozapine non responders
• - Any significant clinical disorder that, in the opinion of the investigator, made the subject unsuitable to be given treatment with an investigational drug
• - An absolute neutrophil count (ANC) of ≤1.5 x 109 per liter
• - Patients who, in the opinion of the investigator, pose an imminent risk of suicide or a danger to self or others.